Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chondrochymal® in Knee Osteoarthritis
NCT05027581Phase 2Completed
- Sponsor
- Taiwan Bio Therapeutics
- Start
- Oct 2021
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Chondrochymal in osteoarthritis (OA), sponsored by Taiwan Bio Therapeutics. Started Oct 2021; status: completed.
02
Drugs
Chondrochymal
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05027581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05027581.